Pharmacokinetics of generic dasatinib in the management of chronic myeloid leukemia in the chronic phase

Objective To evaluate the pharmacokinetics and bioequivalence of generic dasatinib in patients with chronic myeloid leukemia in the choronie phase(CML-CP).Methods Using randomized,parallel,overlapping,self-